Universitätsklinikum Mannheim

Hospital


Location: Mannheim, Germany (DE) DE

ISNI: 0000000121621728

ROR: https://ror.org/05sxbyd35

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Improving medical care and prevention in adults with congenital heart disease-reflections on a global problem-part II: infective endocarditis, pulmonary hypertension, pulmonary arterial hypertension and aortopathy (2018) Neidenbach R, Niwa K, Oto O, Oechslin E, Aboulhosn J, Celermajer D, Schelling J, et al. Journal article CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making (2018) Worst TS, Weis CA, Stoehr R, Bertz S, Eckstein M, Otto W, Breyer J, et al. Journal article Characterization of Checkpoint Inhibitor-associated Diabetes mellitus - Experience in 12 Patients (2018) Satzger I, Momma M, Thoms KM, Eigentler T, Schultz E, Loquai C, Zimmer L, et al. Conference contribution Dry Mouth under Immune Checkpoint Inhibitors: an Analysis of 29 Patients from 10 German Skin Cancer Centers (2018) Hensen J, Thoms KM, Kaehler K, Gutzmer R, Zimmer L, Zacher M, Alter M, et al. Conference contribution Influence of previous Radiotherapy on the Success of an immune-oncologic Therapy in metastatic Melanoma - a retrospective multicenter Study of ADO (2018) Knispel S, Zimmer L, Gutzmer R, Heinzerling L, Weishaupt C, Pfoehler C, Gesierich A, et al. Conference contribution Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening (2018) Rinaldetti S, Rempel E, Worst TS, Eckstein M, Steidler A, Weiss CA, Bolenz C, et al. Journal article Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients (2018) Teramoto Y, Keim U, Gesierich A, Schuler G, Fiedler E, Tueting T, Ulrich C, et al. Journal article Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial (2018) Fokas E, Fietkau R, Hartmann A, Hohenberger W, Grützmann R, Ghadimi M, Liersch T, et al. Journal article The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians (2018) Kähler KC, Blome C, Forschner A, Gutzmer R, Hauschild A, Heinzerling L, Livingstone E, et al. Journal article Patients' and Physicians' Preferences for Systemic Psoriasis Treatments: A Nationwide Comparative Discrete Choice Experiment (PsoCompare) (2018) Schaarschmidt ML, Herr RM, Gutknecht M, Wroblewska K, Gerdes S, Sticherling M, Augustin M, Peitsch WK Journal article